List of Excipients in API inavolisib
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing inavolisib
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Genentech Inc | ITOVEBI | inavolisib | 50242-079 | CELLULOSE, MICROCRYSTALLINE | 2029-10-10 |
| Genentech Inc | ITOVEBI | inavolisib | 50242-079 | FERRIC OXIDE RED | 2029-10-10 |
| Genentech Inc | ITOVEBI | inavolisib | 50242-079 | FERRIC OXIDE YELLOW | 2029-10-10 |
| Genentech Inc | ITOVEBI | inavolisib | 50242-079 | LACTOSE MONOHYDRATE | 2029-10-10 |
| Genentech Inc | ITOVEBI | inavolisib | 50242-079 | MAGNESIUM STEARATE | 2029-10-10 |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for inavolisib
Excipient focus: CELLULOSE, MICROCRYSTALLINE
inavolisib drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Genentech Inc | inavolisib | 50242-079 |
| >Company | >Ingredient | >NDC |
inavolisib drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
inavolisib drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Genentech Inc | inavolisib | 50242-079 |
| >Company | >Ingredient | >NDC |
inavolisib drug variants not containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
inavolisib drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Genentech Inc | inavolisib | 50242-079 |
| >Company | >Ingredient | >NDC |
inavolisib drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
inavolisib drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Genentech Inc | inavolisib | 50242-079 |
| >Company | >Ingredient | >NDC |
inavolisib drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
inavolisib drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Genentech Inc | inavolisib | 50242-079 |
| >Company | >Ingredient | >NDC |
inavolisib drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
inavolisib drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Genentech Inc | inavolisib | 50242-079 |
| >Company | >Ingredient | >NDC |
inavolisib drug variants not containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYVINYL ALCOHOL
inavolisib drug variants containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Genentech Inc | inavolisib | 50242-079 |
| >Company | >Ingredient | >NDC |
inavolisib drug variants not containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A
inavolisib drug variants containing SODIUM STARCH GLYCOLATE TYPE A
| Company | Ingredient | NDC |
|---|---|---|
| Genentech Inc | inavolisib | 50242-079 |
| >Company | >Ingredient | >NDC |
inavolisib drug variants not containing SODIUM STARCH GLYCOLATE TYPE A
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
inavolisib drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Genentech Inc | inavolisib | 50242-079 |
| >Company | >Ingredient | >NDC |
inavolisib drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
inavolisib drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Genentech Inc | inavolisib | 50242-079 |
| >Company | >Ingredient | >NDC |
inavolisib drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch